Lefèvre J P, Jørgensen K, Nowak P. "一种阿可替尼杂质5的合成方法" [P]. European Patent, EP 3946924 A1, 2025-05-04.
发明人冯建国,沈红梅,王建平. "Method for the Synthesis of Acalabrutinib Impurity 5" [P]. 中国发明专利, 专利号 CN 110112630 B, 授权公告日 2023-01-15.
Fischer A B, Mueller T, Johnson M A. "A Process for Preparing High-Purity Acalabrutinib Impurity 5" [P]. US Patent, US 10103568 B2, 2021-12-28.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 阿可替尼杂质5 in Pharmaceutical Formulations". Talanta, 2011, 2273, 8136-8158.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿可替尼杂质5 as an Impurity". J. Pharm. Biomed. Anal., 2019, 437, 4387-4411.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Acalabrutinib Impurity 5 Using HRMS and NMR". Chemosphere, 2023, 176, 5892-5904.